Rob Haefeli has over 20 years of experience in the pharmaceutical industry, currently serving as Head of Field Reimbursement at argenx since 2020 and previously holding the position of Director of Market Access at Alexion Pharmaceuticals, Inc. from 2012 to 2020, where responsibilities included partnering with payers and hospital administrators to ensure access to an Ultra Rare Disease portfolio. Prior to Alexion, Rob was with Amgen from 2004 to 2012, taking on roles such as Director of Diagnostics and Regional Account Manager, focusing on sales across hospitals and nephrology clinics. Rob's career also includes a role as Specialty Sales Account Manager at Novartis from 2001 to 2004, where expertise in therapies for Osteoporosis, Alzheimer’s, and Cardiovascular diseases was developed. Rob holds a Bachelor of Arts degree in Criminology from the University of South Florida.
This person is not in the org chart
This person is not in any teams
This person is not in any offices